|
WASL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.801490E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.904800E-03 |
| Normal-vs-Stage2 |
2.169800E-01 |
| Normal-vs-Stage3 |
5.755400E-04 |
| Normal-vs-Stage4 |
2.017800E-03 |
| Stage1-vs-Stage2 |
2.201600E-01 |
| Stage1-vs-Stage3 |
2.481800E-01 |
| Stage1-vs-Stage4 |
4.029200E-01 |
| Stage2-vs-Stage3 |
7.010300E-02 |
| Stage2-vs-Stage4 |
1.169380E-01 |
| Stage3-vs-Stage4 |
9.638800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.235100E-04 |
| Normal-vs-AfricanAmerican |
3.245200E-01 |
| Normal-vs-Asian |
5.955400E-03 |
| Caucasian-vs-AfricanAmerican |
2.305200E-01 |
| Caucasian-vs-Asian |
8.769600E-01 |
| AfricanAmerican-vs-Asian |
2.731800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.974800E-04 |
| Normal-vs-Female |
4.440900E-03 |
| Male-vs-Female |
3.379200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.475540E-02 |
| Normal-vs-Age(41-60Yrs) |
2.699200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.178680E-03 |
| Normal-vs-Age(81-100Yrs) |
9.140500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.652800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.618600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.864970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.039400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.710200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.473600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.064500E-02 |
| Classical-VS-Follicular |
1.438430E-01 |
| Classical-VS-Other |
3.294000E-01 |
| Classical-VS-Normal |
2.044500E-02 |
| Tall-VS-Follicular |
3.715600E-01 |
| Tall-VS-Other |
9.431400E-01 |
| Tall-VS-Normal |
7.952300E-04 |
| Follicular-VS-Other |
6.596400E-01 |
| Follicular-VS-Normal |
3.839600E-03 |
| Other-VS-Normal |
5.709500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.022850E-03 |
| Normal-vs-N1 |
2.616600E-03 |
| N0-vs-N1 |
7.919000E-01 |
|
|
